115 related articles for article (PubMed ID: 3557673)
1. Biofiltration and calcium-phosphate metabolism.
Bianchi ML; Soldati L; Giaretto S; Valenti G; Cresseri D; Lorenz M; Buccianti G
Int J Artif Organs; 1986 Dec; 9 Suppl 3():51-4. PubMed ID: 3557673
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Short-term plasma phosphate behaviour in biofiltration.
Rocco A; Pitzorno F; Pecorari M; Beltram E; Barnaba A; Barduagni S
Int J Artif Organs; 1986 Dec; 9 Suppl 3():99-101. PubMed ID: 3557686
[No Abstract] [Full Text] [Related]
4. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
5. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone.
Arieff AI; Massry SG
J Clin Invest; 1974 Feb; 53(2):387-92. PubMed ID: 11344551
[TBL] [Abstract][Full Text] [Related]
6. Ionized calcium/total calcium ratio during biofiltration.
Procaccini DA; Chiaravalle A; D'Altilia D; Delli Carri P; Di Gioia V; Muscio A; Salatino G; Tappi A; Passione A
Int J Artif Organs; 1986 Dec; 9 Suppl 3():149-52. PubMed ID: 3557666
[TBL] [Abstract][Full Text] [Related]
7. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
Gray RW; Wilz DR; Caldas AE; Lemann J
J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
[TBL] [Abstract][Full Text] [Related]
8. Removal of phosphate (Pi) by either bicarbonate dialysis or biofiltration in uremics.
Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Morachiello P
Int J Artif Organs; 1986 Dec; 9 Suppl 3():35-8. PubMed ID: 3557670
[TBL] [Abstract][Full Text] [Related]
9. Mineral metabolism during a hemofiltration session in children.
Bianchi ML; Bettinelli A; Soldati L; Saccaggi A; Ortolani S; Edefonti A
Int J Artif Organs; 1986 Jul; 9(4):257-62. PubMed ID: 3781652
[TBL] [Abstract][Full Text] [Related]
10. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Scolari F; Cancarini GC; Maiorca R
Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone, calcium and phosphate balance in hemofiltration.
Fuchs C; Doht B; Dorn D; McIntosh C; Ritter D; Scheler F
J Dial; 1977; 1(6):631-40. PubMed ID: 608872
[TBL] [Abstract][Full Text] [Related]
12. [Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration].
Rius A; Hernández-Jaras J; Pons R; García Pérez H; Torregrosa E; Sánchez Canel JJ; Fenollosa MA; Pin MT; Tamarit E; Calvo C
Nefrologia; 2007; 27(5):593-8. PubMed ID: 18045035
[TBL] [Abstract][Full Text] [Related]
13. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound.
Giannattasio P; Minutolo R; Bellizzi V; Di Iorio BR; Scigliano R; Zamboli P; Venditti G; Manganelli R; De Simone W; Aucella F; Stallone C; Spiezia S; Conte G; De Nicola L
Am J Kidney Dis; 2006 Jun; 47(6):1045-54. PubMed ID: 16731300
[TBL] [Abstract][Full Text] [Related]
14. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
[TBL] [Abstract][Full Text] [Related]
15. Correcting acidosis in hemodialysis: effect on phosphate clearance and calcification risk.
Harris DC; Yuill E; Chesher DW
J Am Soc Nephrol; 1995 Dec; 6(6):1607-12. PubMed ID: 8749687
[TBL] [Abstract][Full Text] [Related]
16. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
17. Serum 25-hydroxyvitamin D and parathyroid hormone in patients with acute renal failure.
Pietrek J; Kokot F; Kuska J
Kidney Int; 1978 Feb; 13(2):178-85. PubMed ID: 713278
[No Abstract] [Full Text] [Related]
18. Interrelations between phosphorus, calcium, parathyroid hormone, and renal phosphate excretion in response to an oral phosphorus load in normal and uremic dogs.
Kaplan MA; Canterbury JM; Gavellas G; Jaffe D; Bourgoignie JJ; Reiss E; Bricker NS
Kidney Int; 1978 Sep; 14(3):207-14. PubMed ID: 723149
[No Abstract] [Full Text] [Related]
19. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
20. Calcium balance and intact PTH variations during haemodiafiltration.
Argilés A; Mion CM
Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
